A detailed history of Retirement Systems Of Alabama transactions in Moderna, Inc. stock. As of the latest transaction made, Retirement Systems Of Alabama holds 73,550 shares of MRNA stock, worth $2.71 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
73,550
Previous 73,213 0.46%
Holding current value
$2.71 Million
Previous $7.8 Million 11.96%
% of portfolio
0.03%
Previous 0.03%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 24, 2024

BUY
$101.21 - $166.61 $34,107 - $56,147
337 Added 0.46%
73,550 $8.73 Million
Q1 2024

Apr 30, 2024

BUY
$85.37 - $115.44 $9,049 - $12,236
106 Added 0.14%
73,213 $7.8 Million
Q4 2023

Feb 05, 2024

SELL
$69.51 - $104.43 $122,407 - $183,901
-1,761 Reduced 2.35%
73,107 $7.27 Million
Q3 2023

Nov 06, 2023

BUY
$96.41 - $126.61 $34,514 - $45,326
358 Added 0.48%
74,868 $7.73 Million
Q2 2023

Jul 31, 2023

SELL
$118.5 - $160.53 $2.74 Million - $3.72 Million
-23,147 Reduced 23.7%
74,510 $9.05 Million
Q1 2023

May 01, 2023

SELL
$135.66 - $197.02 $1.11 Million - $1.61 Million
-8,188 Reduced 7.74%
97,657 $15 Million
Q4 2022

Feb 06, 2023

SELL
$118.38 - $210.04 $698,560 - $1.24 Million
-5,901 Reduced 5.28%
105,845 $19 Million
Q3 2022

Nov 04, 2022

SELL
$118.07 - $194.18 $351,022 - $577,297
-2,973 Reduced 2.59%
111,746 $13.2 Million
Q2 2022

Aug 03, 2022

SELL
$117.13 - $176.59 $252,298 - $380,374
-2,154 Reduced 1.84%
114,719 $16.4 Million
Q1 2022

Apr 20, 2022

SELL
$126.46 - $235.05 $885 - $1,645
-7 Reduced 0.01%
116,873 $20.1 Million
Q4 2021

Jan 20, 2022

SELL
$225.82 - $368.51 $839,147 - $1.37 Million
-3,716 Reduced 3.08%
116,880 $29.7 Million
Q3 2021

Nov 03, 2021

BUY
$221.9 - $484.47 $26.8 Million - $58.4 Million
120,596 New
120,596 $46.4 Million

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $14.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Retirement Systems Of Alabama Portfolio

Follow Retirement Systems Of Alabama and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Retirement Systems Of Alabama, based on Form 13F filings with the SEC.

News

Stay updated on Retirement Systems Of Alabama with notifications on news.